Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 42.99M
March 31, 2026 54.53M
December 31, 2025 66.00M
September 30, 2025 76.94M
June 30, 2025 83.52M
March 31, 2025 89.35M
December 31, 2024 94.43M
September 30, 2024 84.80M
June 30, 2024 101.54M
March 31, 2024 10.09M
December 31, 2023 14.45M
Date Value
September 30, 2023 21.68M
June 30, 2023 25.14M
March 31, 2023 29.77M
December 31, 2022 35.50M
September 30, 2022 39.43M
June 30, 2022 42.92M
March 31, 2022 45.73M
December 31, 2021 49.64M
September 30, 2021 0.4192M
June 30, 2021 1.280M
March 31, 2021 1.660M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. --
EyePoint, Inc. 180.47M
Neumora Therapeutics, Inc. 116.83M
LENZ Therapeutics, Inc. 197.30M
ANI Pharmaceuticals, Inc. 375.87M